Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

NCT04242095 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT04242095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04242095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Observational
Overall status
Recruiting
Start date
March 12, 2020
Completion date
October 1, 2026
Enrollment
2,240 (estimated)
Sites
629

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid cell neoplasm, immune system disorder, malignant solid neoplasm